Metallic Ru, Rh, and Ir nanoparticles were prepared by the decomposition of organometallic precursors under H(2) pressure in the presence of 1,3-diphosphite ligands, derived from carbohydrates, as stabilizing agents. Structural modifications to the diphosphite backbone were found to influence the nanoparticles' size, dispersion, and catalytic activity. In the hydrogenation of o- and m-methylanisole, the Rh nanoparticles showed higher catalytic activity than the corresponding Ru nanoparticles. The Ir nanoparticles presented the lowest catalytic activity of the series. In all cases, the hydrogenation of o-methylanisole gave total selectivity for the cis-product, however, the ee of the product was always less than 6 %. A maximum of 81 % cis-selectivity was obtained for the hydrogenation of m-methylanisole, however, no asymmetric induction was observed. These results show that the catalytic activity is affected by a combination of influences from the substrate, the diphosphite ligands, and the metallic nanoparticles.
No takes yet. Share an insight, caveat, or question.
Gual et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: